Crossmark

Beta-Blockers in Asymptomatic Coronary Artery Disease

Crossref DOI link: https://doi.org/10.1016/j.jacc.2014.04.043

Published Print: 2014-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Steg, Philippe Gabriel

De Silva, Ranil
Funding

Funding for this research was provided by:

Bayer

Servier

Janssen Pharmaceuticals

GlaxoSmithKline

Merck Sharp and Dohme

Novartis

Medicines Company

Roche

Otsuka America

AstraZeneca

Institut National de la Santé et de la Recherche Médicale (U-1148)

Medtronic

Eli Lilly and Company

Pfizer

Boehringer Ingelheim

Sanofi
License Information

Text and Data Mining valid from 2014-07-01

Text and Data Mining valid from 2014-07-01

Version of Record valid from 2015-07-22
More Information

This article is maintained by: Elsevier

Article Title: Beta-Blockers in Asymptomatic Coronary Artery Disease

Journal Title: Journal of the American College of Cardiology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jacc.2014.04.043

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.jacc.2014.04.042

Content Type: simple-article

Copyright: Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.